Aspira Women's Health Inc. (AWHL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 3.5M 7M 10.5M Q3 '21: 6.4M Q4 '21: 6.8M Q1 '22: 7.2M Q2 '22: 7.5M Q3 '22: 7.9M Q4 '22: 8.2M Q1 '23: 8.6M Q2 '23: 9M Q3 '23: 9.2M Q4 '23: 9.2M Q1 '24: 9M Q2 '24: 8.9M Q3 '24: 9M Q4 '24: 9.2M Q1 '25: 9.3M Q2 '25: 9.3M Q3 '25: 9.3M Q4 '25: 9.2M Q1 '26: 8.9M Q2 '26: 8.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 2.5M 5M 7.5M Q3 '21: 2.3M Q4 '21: 3.1M Q1 '22: 3.4M Q2 '22: 3.7M Q3 '22: 4.1M Q4 '22: 4.3M Q1 '23: 4.5M Q2 '23: 5.1M Q3 '23: 5.3M Q4 '23: 5.3M Q1 '24: 5.3M Q2 '24: 5.2M Q3 '24: 5.2M Q4 '24: 5.5M Q1 '25: 5.8M Q2 '25: 5.9M Q3 '25: 6M Q4 '25: 5.9M Q1 '26: 5.4M Q2 '26: 5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q3 '21: -29.7M Q4 '21: -32.6M Q1 '22: -36M Q2 '22: -36.1M Q3 '22: -35M Q4 '22: -31.1M Q1 '23: -28.2M Q2 '23: -24.3M Q3 '23: -19.8M Q4 '23: -18.9M Q1 '24: -17.3M Q2 '24: -17.4M Q3 '24: -17M Q4 '24: -16.3M Q1 '25: -14.8M Q2 '25: -12.2M Q3 '25: -10.1M Q4 '25: -7.9M Q1 '26: -6.9M Q2 '26: -6.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q3 '21: -28.8M Q4 '21: -31.7M Q1 '22: -35M Q2 '22: -36.2M Q3 '22: -34.3M Q4 '22: -29.9M Q1 '23: -27.2M Q2 '23: -21.3M Q3 '23: -18.2M Q4 '23: -16.7M Q1 '24: -14.7M Q2 '24: -16M Q3 '24: -14.8M Q4 '24: -13.1M Q1 '25: -10.3M Q2 '25: -9.5M Q3 '25: -10.8M Q4 '25: -12.8M Q1 '26: -10.3M Q2 '26: -10M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 1.5M 3M 4.5M Q3 '21: 4.1M Q4 '21: 3.8M Q1 '22: 3.8M Q2 '22: 3.8M Q3 '22: 3.8M Q4 '22: 3.9M Q1 '23: 4.1M Q2 '23: 3.9M Q3 '23: 3.9M Q4 '23: 3.9M Q1 '24: 3.7M Q2 '24: 3.8M Q3 '24: 3.8M Q4 '24: 3.7M Q1 '25: 3.5M Q2 '25: 3.4M Q3 '25: 3.4M Q4 '25: 3.3M Q1 '26: 3.5M Q2 '26: 3.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q3 '21: -24.5M Q4 '21: -27.4M Q1 '22: -32.3M Q2 '22: -32.1M Q3 '22: -31.6M Q4 '22: -31.1M Q1 '23: -26.6M Q2 '23: -16.9M Q3 '23: -6M Q4 '23: -2.4M Q1 '24: -1.1M Q2 '24: -8.3M Q3 '24: -14.5M Q4 '24: -12.1M Q1 '25: -10.8M Q2 '25: -8.8M Q3 '25: -6.1M Q4 '25: -7M Q1 '26: -4.3M Q2 '26: -4.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q1 '20: -13.5M Q2 '20: -13.4M Q3 '20: -13.1M Q4 '20: -15.2M Q1 '21: -17M Q2 '21: -20.1M Q3 '21: -24.9M Q4 '21: -27.6M Q1 '22: -32.5M Q2 '22: -32.3M Q3 '22: -31.8M Q4 '22: -31.3M Q1 '23: -26.8M Q2 '23: -17M Q3 '23: -6.1M Q4 '23: -2.4M Q1 '24: -1.2M Q2 '24: -8.3M Q3 '24: -14.6M Q4 '24: -12.2M Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '21: 112M Q3 '21: 112.1M Q1 '22: 7.5M Q2 '22: 7.5M Q3 '22: 7.8M Q1 '23: 8.3M Q2 '23: 8.4M Q3 '23: 9.8M Q1 '24: 11.8M Q2 '24: 12.5M Q3 '24: 15.4M Q1 '25: 21.6M Q2 '25: 35.6M Q3 '25: 36.4M Q1 '26: 45.8M Q2 '26: 44.2M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q1 '21: -0.19 Q2 '21: -0.21 Q3 '21: -0.26 Q4 '21: -4.27 Q1 '22: -5.46 Q2 '22: -6.50 Q3 '22: -7.41 Q4 '22: -3.86 Q1 '23: -3.41 Q2 '23: -2.59 Q3 '23: -2.07 Q4 '23: -1.82 Q1 '24: -1.42 Q2 '24: -1.42 Q3 '24: -1.17 Q4 '24: -0.95 Q1 '25: -0.65 Q2 '25: -0.44 Q3 '25: -0.34 Q4 '25: -0.36 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.